BE848406A - Procede pour la production de preparations aptes a liberer de maniere controlee un compose actif, - Google Patents

Procede pour la production de preparations aptes a liberer de maniere controlee un compose actif,

Info

Publication number
BE848406A
BE848406A BE172413A BE172413A BE848406A BE 848406 A BE848406 A BE 848406A BE 172413 A BE172413 A BE 172413A BE 172413 A BE172413 A BE 172413A BE 848406 A BE848406 A BE 848406A
Authority
BE
Belgium
Prior art keywords
release
production
active compound
controlled way
preparations suitable
Prior art date
Application number
BE172413A
Other languages
English (en)
French (fr)
Inventor
C B Bogentoft
C H Appelgren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE848406A publication Critical patent/BE848406A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
BE172413A 1975-11-17 1976-11-17 Procede pour la production de preparations aptes a liberer de maniere controlee un compose actif, BE848406A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7512883A SE418247B (sv) 1975-11-17 1975-11-17 Sett att framstella kroppar med reglerad frigoring av en aktiv komponent

Publications (1)

Publication Number Publication Date
BE848406A true BE848406A (fr) 1977-05-17

Family

ID=20326096

Family Applications (1)

Application Number Title Priority Date Filing Date
BE172413A BE848406A (fr) 1975-11-17 1976-11-17 Procede pour la production de preparations aptes a liberer de maniere controlee un compose actif,

Country Status (24)

Country Link
US (2) US4289795A (hu)
JP (1) JPS5919526B2 (hu)
AT (1) AT354636B (hu)
AU (1) AU508266B2 (hu)
BE (1) BE848406A (hu)
CA (1) CA1075031A (hu)
CS (1) CS207374B2 (hu)
DD (1) DD128170A5 (hu)
DE (1) DE2651176A1 (hu)
DK (1) DK146213C (hu)
FI (1) FI62462C (hu)
FR (1) FR2331375A1 (hu)
GB (1) GB1560841A (hu)
HK (1) HK14683A (hu)
HU (1) HU173461B (hu)
IE (1) IE44353B1 (hu)
LU (1) LU76215A1 (hu)
MY (1) MY8400019A (hu)
NL (1) NL187259C (hu)
NO (1) NO144763C (hu)
NZ (1) NZ182621A (hu)
SE (1) SE418247B (hu)
SU (1) SU1326180A3 (hu)
ZA (1) ZA766669B (hu)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS5911563B2 (ja) * 1980-02-27 1984-03-16 日本原子力研究所 多層構造の徐放性複合体を製造する方法
DE3264867D1 (en) * 1981-04-27 1985-08-29 Haessle Ab New pharmaceutical preparation
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
EP0094123A3 (en) * 1982-05-06 1984-07-25 THE PROCTER & GAMBLE COMPANY Therapeutic granules
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
WO1984000004A1 (en) * 1982-06-14 1984-01-05 Key Pharma Sustained release aspirin
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
WO1984000295A1 (en) * 1982-07-09 1984-02-02 Key Pharma Sustained release quinidine dosage form
CA1223172A (en) * 1982-09-23 1987-06-23 Sidney Melamed Encapsulated solid microbiocidal article
US5283060A (en) * 1982-09-29 1994-02-01 Shieh Tsuong R Bacillus-containing pesticide granules
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
GB2141023B (en) * 1983-06-06 1986-09-03 Robins Co Inc A H Delayed release formulations
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
SE458576B (sv) * 1985-06-20 1989-04-17 Lejus Medical Ab Foerfarande foer framstaellning av en guar-gum produkt
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US4826688A (en) * 1985-11-13 1989-05-02 501 Elan Corporation PLC. Controlled absorption pharmaceutical formulation
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
US5100592A (en) * 1986-03-12 1992-03-31 Washington University Technology Associated, Inc. Method and apparatus for granulation and granulated product
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
WO1988004922A1 (en) * 1986-12-25 1988-07-14 Teysan Pharmaceuticals Co., Ltd. Slowly soluble granule and persistently effective composite granule prepared therefrom
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
HU197519B (en) * 1987-06-22 1989-04-28 Biogal Gyogyszergyar Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
EP0297650A1 (en) * 1987-06-26 1989-01-04 Duphar International Research B.V Compositions with controlled zero-order delivery rate and method of preparing these compositions
US5219575A (en) * 1987-06-26 1993-06-15 Duphar International Research B.V. Compositions with controlled zero-order delivery rate and method of preparing these compositions
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten
IT1231410B (it) * 1987-09-22 1991-12-04 Cooperativa Farmaceutica Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US4971796A (en) * 1988-10-05 1990-11-20 Sjogren Robert D Slow release pest control granule composition
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
EP0376331A3 (en) * 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
DE3918801A1 (de) * 1989-06-06 1991-05-08 Schmidt Walter Praeparat zur geregelten wirkstoffabgabe und verfahren zu dessen herstellung
JP2813809B2 (ja) * 1989-06-19 1998-10-22 武田薬品工業株式会社 有核顆粒製剤およびその製造法
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
JPH0733645A (ja) * 1992-05-28 1995-02-03 Elan Corp Plc 錠剤製剤
EP0675710B1 (en) * 1992-12-23 1999-08-25 Saitec S.R.L. Process for preparing controlled release pharmaceutical forms and the forms thus obtained
IT1274879B (it) * 1994-08-03 1997-07-25 Saitec Srl Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
DE4446468A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von umhüllten Tabletten
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
NZ515911A (en) * 1999-06-04 2004-02-27 Alza Corp Implantable gel compositions and method of manufacture
EP1949890A3 (en) 1999-06-04 2011-05-18 ALZA Corporation Implantable gel compositions and method of manufacture
PT1276470E (pt) 2000-04-20 2007-08-13 Novartis Ag Composição de revestimento para dissimular o sabor
KR100402053B1 (ko) * 2000-09-28 2003-10-17 한국화학연구원 항생제의 서방성 임플란트 제제
GB0027357D0 (en) * 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
ES2663873T3 (es) * 2001-10-29 2018-04-17 Massachusetts Institute Of Technology Forma farmacéutica con perfil de liberación de orden cero fabricada por impresión tridimensional
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
GB0228421D0 (en) * 2002-12-05 2003-01-08 Exosect Ltd Lipid carriers
DE10260919A1 (de) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
GB0310636D0 (en) * 2003-05-08 2003-06-11 Nektar Therapeutics Uk Ltd Particulate materials
WO2004098561A2 (en) 2003-05-08 2004-11-18 Nektar Therapeutics Uk Ltd Particulate materials
CA2556943A1 (en) * 2004-03-31 2005-10-20 Eid Parry (India) Limited Improved granular formulation of neem seed extract and its process thereof
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
DE602006007538D1 (de) * 2005-01-06 2009-08-13 Cima Labs Inc Geschmacksunterdrückungssystem für nicht geweichte arzneimittel
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
BE623704A (hu) * 1961-10-20
US3383283A (en) * 1964-01-24 1968-05-14 Merck & Co Inc Medicinal pellets coated with overlapping porous fatty acid leaflet layers
FR1545612A (fr) * 1967-06-15 1968-11-15 Dausse Lab Procédé de fabrication de comprimés
DE1617351A1 (hu) * 1967-06-28 1972-01-05
DK123806B (da) * 1970-06-08 1972-08-07 Pharmacia As Fremgangsmåde til fremstilling af tabletter eller piller med langsom afgivelse af et aktivt stof.
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
BE792502A (fr) * 1971-12-09 1973-06-08 Upjohn Co Nouvelles formes pharmaceutiques et leur procede de preparation

Also Published As

Publication number Publication date
DE2651176A1 (de) 1977-05-18
MY8400019A (en) 1984-12-31
DD128170A5 (de) 1977-11-02
SU1326180A3 (ru) 1987-07-23
NL187259C (nl) 1991-08-01
IE44353B1 (en) 1981-11-04
IE44353L (en) 1977-05-17
GB1560841A (en) 1980-02-13
AU1961776A (en) 1978-05-25
LU76215A1 (hu) 1977-06-06
NO763807L (hu) 1977-05-20
DK146213C (da) 1984-01-16
CA1075031A (en) 1980-04-08
NL187259B (nl) 1991-03-01
ZA766669B (en) 1977-10-26
US4289795A (en) 1981-09-15
JPS5919526B2 (ja) 1984-05-07
DK146213B (da) 1983-08-01
FI62462C (fi) 1983-01-10
DK513476A (da) 1977-05-18
SE7512883L (sv) 1977-05-18
US4341759A (en) 1982-07-27
HU173461B (hu) 1979-05-28
NO144763B (no) 1981-07-27
AU508266B2 (en) 1980-03-13
SE418247B (sv) 1981-05-18
CS207374B2 (en) 1981-07-31
FI62462B (fi) 1982-09-30
JPS5283921A (en) 1977-07-13
NO144763C (no) 1981-11-04
FI763257A (hu) 1977-05-18
NL7612728A (nl) 1977-05-20
HK14683A (en) 1983-05-13
NZ182621A (en) 1978-12-18
FR2331375B1 (hu) 1981-12-31
AT354636B (de) 1979-01-25
ATA850576A (de) 1979-06-15
FR2331375A1 (fr) 1977-06-10
DE2651176C2 (hu) 1987-06-11

Similar Documents

Publication Publication Date Title
BE848406A (fr) Procede pour la production de preparations aptes a liberer de maniere controlee un compose actif,
BE838754A (fr) Procede ameliore pour la preparation de dimethylol-2, 2-alcanals
FR2320904A1 (fr) Procede de preparation de phosphates alcalins de haute purete
EG11278A (en) Process for preparing prostanoic acid derivatives
YU153273A (en) Process for preparing bis(4-hydroxy-3, 5-ditert-butyl-phenyl)-ethanoic acid
EG11139A (en) Process for preparing of 7(d-alpha-amino-1,4-cyclohexadien-1-ylacetamido)desacetoxycephalosporanic acid dihydrate
KE2771A (en) Substituted pyrimidine-thionothiolphosphoric acid esters, process for their preparation and their use as insecticides or acaricides
YU179173A (en) Process for preparing 7-amino-3-cephem-4-carboxylic acid compounds
ZA74346B (en) O-ethyl-s-n-propyl-o-vinyl-thionothiolphosphoric acid esters,a process for their preparation and their use as insecticides or acaricides
FR2334658A1 (fr) Procede de preparation de phenylglycinamide optiquement actif
ZA745526B (en) Novel thionothiolphosphoric acid esters, process for their preparation and their use insecticides and acaricides
YU332373A (en) Process for obtaining pregnanic acid derivatives
ZA747790B (en) Process for the preparation of citric acid esters, citric acid or salts of citric acid
FR2298554A1 (fr) Procede de preparation de thymidine-phosphorylase, et preparation stabilisee obtenue
YU179579A (en) Process for preparing indole-carboxylic acid derivatives
GR60041B (en) Substituted 4-phenyl-imidazolines,their salts by acid addition and process for their preparation
CS179981B2 (en) Method for production of novel 2-substituted 3-tertiary butyl-5-/3,5-dichlor-4-aminophenyl/oxazolidines
BE847542A (fr) Procede de preparation de phosphorodihalogenodithioates de s-alkyle,
FR2317297A1 (fr) Procede de preparation de la d,l pantolactone
ZA738400B (en) Terahydroindazole-5-carboxylic acid compounds,and metal salts thereof,and processes for their production
EG11579A (en) 2-cyanophenyldithiophosphoric acid esters,process for their preparation and their use as insecticides or acaricides
EG10742A (en) Naphthisoxazole-thionophosphoric acid esters,process for their production and their use as insecticides or acaricides
BE802359A (fr) Procede de preparation de pepsine a haute activite
FR2313334A1 (fr) Procede de preparation de 1,1-dihalogeno-1,3-dienes
YU35367B (en) Process for preparing esters of 0,0-dialkyl-0-(2,2-dichlorovinyl)-thinophosphoric acid

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: HASSLE A.B.

Effective date: 19931130